All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Why should we perform PET-CT in a patient with SMM?

May 7, 2021

During the European School of Haematology (ESH) 3rd How to Diagnose and Treat Multiple Myeloma conference, the Multiple Myeloma Hub spoke to Cristina Nanni, IRCCS S. Orsola Malpighi Hospital, Bologna, IT. We asked, Why should we perform PET-CT in a patient with SMM?

Nanni discusses the application of low-dose PET-CT (positron emission tomography–computed tomography) scans to confirm diagnosis and determine the prognosis of patients with smoldering multiple myeloma (SMM).